Literature DB >> 20795773

Premarital screening test results for β-thalassemia and sickle cell anemia trait in east Mediterranean region of Turkey.

Ekrem Guler1, Mesut Garipardic, Tahir Dalkiran, Mehmet Davutoglu.   

Abstract

Hemoglobinopathies are common diseases in Mediterranean region of Turkey. In this study, the results of a 3-year premarital screening program are reported in Kahramanmaras province, which is located in East Mediterranean region. A total of 48,126 persons were screened in this program. Hematological analyses and electrophoresis were done to identify carriers. The prevalence of β-thalassemia trait and of sickle cell anemia trait, which were 2.1% and 0.5% in Turkey, were found to be 2.8% and 0.4%, respectively, in our study. Of the carriers of the β-thalassemia trait, 82% had high hemoglobin A₂, 34% had high hemoglobin F, and 18% had both high hemoglobin F and hemoglobin A₂. β-Thalassemia trait in Kahramanmaras is slightly higher than the average rate in Turkey. However, sickle cell anemia trait is similar to Turkey's averages.

Entities:  

Mesh:

Year:  2010        PMID: 20795773     DOI: 10.3109/08880018.2010.503772

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  3 in total

1.  Sickle cell trait and multisystem trauma: an unaddressed urgent knowledge gap.

Authors:  Frazer A Tessema; Gabrielle Lapping-Carr; Murtala I Affini; Isaiah K Selkridge; Akosua Y Oppong; Tanisha A Jones; Tanya Zakrison
Journal:  Trauma Surg Acute Care Open       Date:  2022-06-05

2.  Evaluation and cost analysis of national health policy of thalassaemia screening in west-azerbaijan province of iran.

Authors:  Elham Ahmadnezhad; Nariman Sepehrvand; Farshid Fayyaz Jahani; Sanaz Hatami; Catauon Kargar; Majid Mirmohammadkhani; Shahrzad Bazargan-Hejazi
Journal:  Int J Prev Med       Date:  2012-10

3.  Premarital Screening of Beta Thalassemia Minor in north-east of Iran.

Authors:  H Hashemizadeh; R Noori
Journal:  Iran J Ped Hematol Oncol       Date:  2013-01-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.